To date, few markers like the estrogen receptor (ER), the progesterone receptor (PR) and the human epidermal growth factor receptor 2 (HER2), have been identified as predictors of clinical responses to breast cancer treatments [47]. The gene discussed is ESR1; the disease is breast cancer.